Doctor faces sentencing for 'over the top' cancer drug dosing

A Detroit doctor used a "beyond aggressive" approach to cancer treatment to reap millions in drug reimbursements, an expert witness said as the oncologist's criminal trial opened Monday. Dr. Farid Fata is accused of giving hundreds of unnecessary infusions--sometimes more than 100 to one patient--of powerful drugs such as Roche ($RHHBY) and Biogen's ($BIIB) Rituxan, triggering intense side effects. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.